Dr. Moshfeghi focuses on the practical application of existing technology to ensure that all eligible infants at-risk for retinopathy of prematurity (ROP) are screened in a timely and effective manner. This has been achieved through the development of two separate telemedicine screening programs using wide-angle digital images: 1) Stanford University Network for the Diagnosis of Retinopathy of Prematurity (SUNDROP), and 2) Telemedicine for ROP (TeleROP), a collaboration between Stanford University and Pediatrix, a national provider of pediatric healthcare services. Together, SUNDROP and TeleROP cover nearly 2% of available neonatal intensive care units (NICUs) in the United States.